Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity
Robert Hauffe, … , Anna P. Kipp, André Kleinridders
Robert Hauffe, … , Anna P. Kipp, André Kleinridders
Published May 5, 2020
Citation Information: JCI Insight. 2020;5(11):e136283. https://doi.org/10.1172/jci.insight.136283.
View: Text | PDF
Research Article Endocrinology Metabolism

GPx3 dysregulation impacts adipose tissue insulin receptor expression and sensitivity

  • Text
  • PDF
Abstract

Insulin receptor signaling is crucial for white adipose tissue (WAT) function. Consequently, lack of insulin receptor (IR) in WAT results in a diabetes-like phenotype. Yet, causes for IR downregulation in WAT of patients with diabetes are not well understood. By using multiple mouse models of obesity and insulin resistance, we identify a common downregulation of IR with a reduction of mRNA expression of selenoproteins Txnrd3, Sephs2, and Gpx3 in gonadal adipose tissue. Consistently, GPX3 is also decreased in adipose tissue of insulin-resistant and obese patients. Inducing Gpx3 expression via selenite treatment enhances IR expression via activation of the transcription factor Sp1 in 3T3-L1 preadipocytes and improves adipocyte differentiation and function. Feeding mice a selenium-enriched high-fat diet alleviates diet-induced insulin resistance with increased insulin sensitivity, decreased tissue inflammation, and elevated IR expression in WAT. Again, IR expression correlated positively with Gpx3 expression, a phenotype that is also conserved in humans. Consequently, decreasing GPx3 using siRNA technique reduced IR expression and insulin sensitivity in 3T3-L1 preadipocytes. Overall, our data identify GPx3 as a potentially novel regulator of IR expression and insulin sensitivity in adipose tissue.

Authors

Robert Hauffe, Vanessa Stein, Chantal Chudoba, Tanina Flore, Michaela Rath, Katrin Ritter, Mareike Schell, Kristina Wardelmann, Stefanie Deubel, Johannes Florian Kopp, Maria Schwarz, Kai Kappert, Matthias Blüher, Tanja Schwerdtle, Anna P. Kipp, André Kleinridders

×

Figure 2

Selenite treatment increases IR expression and sensitivity in white adipocytes.

Options: View larger image (or click on image) Download as PowerPoint
Selenite treatment increases IR expression and sensitivity in white adip...
(A) Ir expression in 3T3-L1 preadipocytes after selenite treatment. (B) Representative IR expression in 3T3-L1 preadipocytes after selenite treatment (densitometry n = 12). (C) Gpx3 mRNA expression in 3T3-L1 preadipocytes after selenite treatment. (D) Western blot of members of the insulin signaling pathway and selenoprotein GPx1 after selenite and insulin treatment. (E) Representative microscopic image of Oil Red O staining and quantification of differentiated 3T3-L1 adipocytes after selenite treatment (n = 6). Original magnification, ×100; side length, 500 µm. (F) Expression profile of adipocyte markers and selenoproteins of differentiated 3T3-L1 adipocytes after selenite treatment (n = 12). (G) Expression profile of adipocyte markers and selenoproteins of undifferentiated 3T3-L1 preadipocytes after selenite treatment (n = 6). (H) Uptake of 14C-labeled deoxy-d-glucose (14C-DOG) in differentiated 3T3-L1 adipocytes after selenite treatment (n = 4). (I) Ir mRNA expression in 3T3-L1 preadipocytes after selenite and 24 hours’ mithramycin treatment; data were normalized to untreated control (condition C; n = 6). (J) Oil Red O quantification of differentiated 3T3-L1 adipocytes after selenite and mithramycin treatment (n = 4). *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 after 2-tailed Student’s t test. #P < 0.05 after 2-way ANOVA and Holm-Šídák post hoc test. All data are presented as mean ± SEM. C, control; Se, 200-nM selenite treatment.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts